Oncocytic papillary renal cell carcinoma with solid architecture: Mimic of renal oncocytoma

Pathology International

Volumn 58, Issue 3, 2008, Pages 164-168

  Mai, Kien T ^a   Kohler, Derek M ^b   Robertson, Susan J ^b   Belanger, Eric C ^b   Marginean, E Celia ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b NONE

Author keywords

Carcinoma; Kidney; Oncocytoma; Papillary

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN 7; PROGESTERONE RECEPTOR; STEM CELL FACTOR RECEPTOR; VIMENTIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KIDNEY CARCINOMA; METASTASIS; ONCOCYTOMA; PRIORITY JOURNAL; RENAL ONCOCYTOMA; TUMOR NECROSIS; TUMOR VOLUME;

ADENOMA, OXYPHILIC; CARCINOMA, PAPILLARY; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY NEOPLASMS; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 38849167406     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2007.02205.x     Document Type: Article

References (37)

1. Murphy WM, Beckwith JB, Farrow GM. Tumor of adults. In:Murphy WM, Beckwith JB, Farrow GM, eds. Atlas of Tumor Pathology, Tumours of the Kidney, Bladder, and Related Urinary Structures, 3rd series. Washington, DC:Armed Force Institute of Pathology, 1994 92 136.
2. Kovacs G, Akhtar M, Beckwith BJ et al. The Heidelberg classification of renal cell tumours. J Pathol 1997 183:131 3.
3. Kovacs G. Molecular differential pathology of renal tumours. Histopathology 1993 22:1 8.
4. Renshaw AA, Zhang H, Corless CL, Fletcher JA, Pins MR. Solid variants of papillary (chromophil) renal cell carcinoma: Clinicopathologic and genetic features. Am J Surg Pathol 1997 21:1203 9.
5. Hes O, Brunelli M, Michal M et al. Oncocytic papillary renal cell carcinoma: A clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases. Ann Diagn Pathol 2006 10:133 9.
6. Lefevre M, Couturier J, Sibony M et al. Adult papillary renal tumor with oncocytic cells: Clinicopathologic, immunohistochemical, and cytogenetic features of 10 cases. Am J Surg Pathol 2005 29:1576 81.
7. Jockle GA, Toker C, Shamsuddin AM. Metastatic renal oncocytic neoplasm with benign histologic appearance. Urology 1987 30:79 81.
8. Amin R, Anthony P. Metastatic renal oncocytoma: A case report and review of the literature. Clin Oncol (R Coll Radiol) 1999 11:277 9.
9. Memeo L, Jhang J, Assaad AM et al. Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: Value in the differential diagnosis of chromophobe cell carcinoma. Am J Clin Pathol 2007 127:225 9.
10. Kruger S, Sotlar K, Kausch I, Horny HP. Expression of KIT (CD117) in renal cell carcinoma and renal oncocytoma. Oncology 2005 68:269 75.
11. Kato N, Honma K, Hojo H, Sasou S, Matsuzaki O, Motoyama T. KIT expression in normal and neoplastic renal tissues: Immunohistochemical and molecular genetic analysis. Pathol Int 2005 55:479 83.
12. Wang HY, Mills SE. KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma. Am J Surg Pathol 2005 29:640 46.
13. Huo L, Sugimura J, Tretiakova MS et al. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas. Hum Pathol 2005 36:262 8.
14. Li G, Gentil-Perret A, Lambert C, Genin C, Tostain J. S100A1 and KIT gene expressions in common subtypes of renal tumours. Eur J Surg Oncol 2005 31:299 303.
15. Pan CC, Chen PC, Chiang H. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma. Am J Clin Pathol 2004 121:878 83.
16. Miliaras D, Karasavvidou F, Papanikolaou A, Sioutopoulou D. KIT expression in fetal, normal adult, and neoplastic renal tissues. J Clin Pathol 2004 57:463 6.
17. Petit A, Castillo M, Santos M, Mellado B, Alcover JB, Mallofre C. KIT expression in chromophobe renal cell carcinoma: Comparative immunohistochemical analysis of KIT expression in different renal cell neoplasms. Am J Surg Pathol 2004 28:676 8.
18. Memeo L, Jhang J, Assaad AM et al. Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: Value in the differential diagnosis of chromophobe cell carcinoma. Am J Clin Pathol 2007 127:225 9.
19. Mazal PR, Stichenwirth M, Koller A, Blach S, Haitel A, Susani M. Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: A tissue microarray study. Mod Pathol 2005 18:535 40.
20. Daniel L, Lechevallier E, Giorgi R et al. Pax-2 expression in adult renal tumors. Hum Pathol 2001 32:282 7.
21. Skinnider BF, Amin MB. An immunohistochemical approach to the differential diagnosis of renal tumors. Semin Diagn Pathol 2005 22:51 68.
22. Abrahams NA, MacLennan GT, Khoury JD et al. Chromophobe renal cell carcinoma: A comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray. Histopathology 2004 45:593 602.
23. Pan CC, Chen PC, Ho DM. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: An immunohistochemical analysis of 328 cases. Histopathology 2004 45:452 9.
24. Avery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol 2000 24:203 10.
25. Molinie V, Balaton A, Rotman S et al. Alpha-methyl CoA racemase expression in renal cell carcinomas. Hum Pathol 2006 37:698 703.
26. Mete O, Kilicaslan I, Gulluoglu MG, Uysal V. Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis. Virchows Arch 2005 447:938 46.
27. Teo I, Roustan Delatour N, Robertson SJ, Marginean EC, Mai KT. Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma. Histopathology (In press).
28. Bhat HK, Hacker HJ, Bannasch P, Thompson EA, Liehr JG. Localization of estrogen receptors in interstitial cells of hamster kidney and in estradiol-induced renal tumors as evidence of the mesenchymal origin of this neoplasm. Cancer Res 1993 53:5447 51.
29. Potier M, Elliot SJ, Tack I et al. Expression and regulation of estrogen receptors in mesangial cells: Influence on matrix metalloproteinase-9. J Am Soc Nephrol 2001 12:241 51.
30. Mai KT, Elkeilani A, Veinot JP. Mixed epithelial and stromal tumour (MEST) of the kidney: Report of 14 cases with male and PEComatous variants and proposed histopathogenesis. Pathology 2007 39:235 40.
31. Jakse G, Muller-Holzner E. Hormone receptors in renal cancer: An overview. Semin Surg Oncol 1988 4:161 4 (Review).
32. Langner C, Ratschek M, Rehak P, Schips L, Zigeuner R. Steroid hormone receptor expression in renal cell carcinoma: An immunohistochemical analysis of 182 tumors. J Urol 2004 171:611 14.
33. Allory Y, Ouazana D, Boucher E, Thiounn N, Vieillefond A. Papillary renal cell carcinoma. Prognostic value of morphological subtypes in a clinicopathologic study of 43 cases. Virchows Arch 2003 442:336 42.
34. Sika-Paotonu D, Bethwaite PB, McCredie MR, William Jordan T, Delahunt B. Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. Am J Surg Pathol 2006 30:1091 6.
35. Delahunt B, Eble JN, McCredie MR, Bethwaite PB, Stewart JH, Bilous AM. Morphologic typing of papillary renal cell carcinoma: Comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 2001 32:590 95.
36. Renshaw AA, Loughlin KR, Dutta A. Cyclin A and MIB1 (Ki67) as markers of proliferative activity in primary renal neoplasms. Mod Pathol 1998 11:963 6.
37. Tickoo SK, Amin MB, Linden MD, Zarbo RJ. The MIB-1 tumor proliferation index in adult renal epithelial tumors with granular cytoplasm: Biologic implications and differential diagnostic potential. Mod Pathol 1998 11:1115 21.